Apteka Arnikasp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-11-30
Share capital
5,000.00 PLN
Registered address
ul. Piłsudskiego 16, 39-200 Dębica, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 221 days for 2022).

  • 2025not filed
  • 202428/09/2025
  • 202315/08/2024
  • 202221/02/2024
  • 202130/12/2022
  • 202018/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 3.23mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 0.00MedianUSD 20.70kAverageUSD 86.70k
Operating costs
This companyUSD 3.06mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 1.16mMedianUSD 543.65kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Apteka Arnika has been an NFZ healthcare provider since 2016. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Provision of medical devicespodkarpackie1USD 0.00

Authorized Representatives

Małgorzata Jarosińska Osak – Management Board Member
Krzysztof Jan Jarosiński – President of the Management Board
Stanisława Jarosińska – Management Board Member

Manner of representation

Each member of the management board may independently represent the company.

Ownership

OwnerSharesShare valueStake
Stanisława Jarosińskaage 73
100$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2015-11-30.

  • 63 2340 0009 1820 2400 0000 0194
  • PKO Bank Polski
    07 1020 4405 0000 2702 0506 1454

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $13,345.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,130
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,798
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,029

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Ms-Pharmsp. z o.o. + limited partnership
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Novopharm - Millersp. j.
Pikadasp. z o.o.
Vitasp. z o.o.
Gold Lionsp. z o.o.
Grupa Aptekarska Kujałowiczsp. j.

FAQ

Last updated: 2026-10-07